Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F4E3A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,355
Award facts
- Contract value 100% obligated
- $15,355.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens with a firm fixed price ceiling value of $15,355.11. This is a non-set-aside competitive award with an ultimate completion date of January 6, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply needs through open competition, ranging from small-value transactions to substantial orders. This delivery order for Cosentyx, a specialty biologic medication used to treat inflammatory conditions, represents one of numerous pharmaceutical products the company supplies through its prime vendor contract to support military healthcare worldwide.
Quick answers
Who was awarded contract SPE2DR26F4E3A?
SPE2DR26F4E3A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F4E3A worth?
The government has obligated $15,355 on SPE2DR26F4E3A.
Is contract SPE2DR26F4E3A an order under another contract?
Yes. SPE2DR26F4E3A is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E3A competed?
The extent of competition for SPE2DR26F4E3A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award